Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Cryopreserved Allogeneic Peripheral Blood Stem Cells Result in Outcome Equivalent to Those of Fresh Infusions Enabling Rational Scheduling of Donations,

Bhuvan Kishore, John Davis, Katayoun Rezvani, MD, PhD, David Marin, Richard M Szydlo, Loaiza Sandra, Giles Chrissy, Aristeidis Chaidos, Edward J Kanfer, Anastasios Karadimitris, Donald H MacDonald, Dragana Milojkovic, MD, Amin Rahemtulla, John M Goldman, Jane F Apperley, MBChB, MD, FRCP, FRCPath, Jiri Pavlu

Blood (2011) 118 (21): 4052.

https://doi.org/10.1182/blood.V118.21.4052.4052

Published: 2011

Journal Articles

Chronic Myeloid Leukemia Patients on Tyrosine Kinase Inhibitor Have Normal T Cell Responses to Vaccination but An Impaired IgM Humoral Response Associated with Loss of Discrete Memory B Cell Subsets,

Blood (2011) 118 (21): 3753.

https://doi.org/10.1182/blood.V118.21.3753.3753

Published: 2011

Journal Articles

Elevated Preconditioning Serum Levels of C-Reactive Protein Are Associated with Increased Nonrelapse Mortality and Inferior Survival After Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation

Jiri Pavlu, Katayoun Rezvani, Bhuvan Kishore, Rifca Le Dieu, Joydeep Chakrabartty, Aristeidis Chaidos, Edward J Kanfer, Anastasios Karadimitris, Donald H MacDonald, David Marin, Dragana Milojkovic, MD, Farah O'Boyle, Amin Rahemtulla, David Slade, John M Goldman, Jane F Apperley, MBChB, MD, FRCP, FRCPath, Richard M Szydlo

Blood (2011) 118 (21): 1945.

https://doi.org/10.1182/blood.V118.21.1945.1945

Published: 2011

Journal Articles

Prolonged Survival Following Imatinib Failure for CML Patients in CP May Require Multiple TKI Strategies for Responding Patients,

Dragana Milojkovic, MD, Jane F Apperley, MBChB, MD, FRCP, FRCPath, Amr R Ibrahim, Marco Bua, MD, Alistair Reid, PhD, Gareth Gerrard, PhD, Letizia Foroni, MD PhD, Katy Rezvani, MBBS, PhD, MRCP, FRCPath, John M Goldman, David Marin

Blood (2011) 118 (21): 3777.

https://doi.org/10.1182/blood.V118.21.3777.3777

Published: 2011

Journal Articles

Thrombopoietic Agonists Show Efficacy in ITP Related to Allogeneic Stem Cell Transplantation,

Emma M O'Donovan, MBBS BSc MRCP MRCPath, Katy Rezvani, MBBS, PhD, MRCP, FRCPath, Jeremy Sargent, MD, MRCP, FRCPath, Deborah Richardson, MD, FRCP, FRCPath, MA, MBBChir, Hannah Tharmalingam, Paul Veys, MD MRCP FRCPath, Jane F Apperley, MBChB, MD, FRCP, FRCPath, Nichola Cooper, MA MD MRCP FRCPath

Blood (2011) 118 (21): 3292.

https://doi.org/10.1182/blood.V118.21.3292.3292

Published: 2011

Journal Articles

Initial Findings From the PACE Trial: A Pivotal Phase 2 Study of Ponatinib in Patients with CML and Ph+ ALL Resistant or Intolerant to Dasatinib or Nilotinib, or with the T315I Mutation

Blood (2011) 118 (21): 109.

https://doi.org/10.1182/blood.V118.21.109.109

Published: 2011

Journal Articles

Allogeneic Stem Cell Transplantation Induces Long Term Survival in Pateitns with Advanced Chronic Myeloid Leukaemia:A Study of the British Society for Blood and Marrow Transplantation,

Gordon Cook, Keiren Kirkland, Julia Lee, Rachel M Pearce, Jane F Apperley, MBChB, MD, FRCP, FRCPath, Richard E. Clark, MD, Stephen Mackinnon, MD, David I. Marks, MBBS, PHD

Blood (2011) 118 (21): 4125.

https://doi.org/10.1182/blood.V118.21.4125.4125

Published: 2011

Journal Articles

The Majority of Patients Receiving Donor Lymphocyte Infusions for Relapsed Chronic Myeloid Leukemia Remain PCR Positive Despite Maintaining Long-Term Remission,

Andrew J Innes, MBChB, James Lurkins, Richard M Szydlo, Andrea Guerra, Dragana Milojkovic, MD, Jiri Pavlu, Edward J Kanfer, David Marin, Donald MacDonald, Amin Rahemtulla, Sandra Loaiza, Stephanie Kirschke, Katayoun Rezvani, MD, PhD, John Goldman, Jane F Apperley, MBChB, MD, FRCP, FRCPath, Francesco Dazzi

Blood (2011) 118 (21): 4103.

https://doi.org/10.1182/blood.V118.21.4103.4103

Published: 2011

Journal Articles

Stem Cell Mobilization in Poor Mobilizers Using Plerixafor and G-CSF with or without Chemotherapy: A European Perspective

Maximilian M Fresen, MD, Rafael F. Duarte, MD, PhD, Jane F Apperley, MBChB, MD, FRCP, FRCPath, Grzegorz Basak, MD, PhD, Kenneth W Douglas, MD, Ian H Gabriel, MD, Catarina Geraldes, MD, Ozren Jaksic, MD, PhD, Zdenek Koristek, MD, PhD, Nicolaus Kröger, Francesco Lanza, MD, Roberto M. Lemoli, MD, Gabor Mikala, MD, PhD, Dominik Selleslag, MD, Nina Worel, MD, Florian Lange, Mohamad Mohty, Kai Hübel, MD

Blood (2011) 118 (21): 2993.

https://doi.org/10.1182/blood.V118.21.2993.2993

Published: 2011

Journal Articles

The Natural History of RTQ-PCR Levels After the Achievement of Complete Molecular Remission (CMR): Implications for ‘Stopping' Studies

Dragana Milojkovic, MD, Gareth Gerrard, PhD, Christos Paliompeis, Marco Bua, MD, Alistair Reid, PhD, Mary Alikian, Jamshid Khorashad, MD, PhD, John M Goldman, David Marin, Letizia Foroni, MD PhD, Jane F Apperley, MBChB, MD, FRCP, FRCPath

Blood (2011) 118 (21): 605.

https://doi.org/10.1182/blood.V118.21.605.605

Published: 2011

Journal Articles

The Predictive Value of Early Molecular Response in Chronic Phase CML Patients Treated with Dasatinib First Line Therapy

David Marin, Corinne Hedgley, Richard E Clark, Jane F Apperley, MBChB, MD, FRCP, FRCPath, Letizia Foroni, MD PhD, Dragana Milojkovic, MD, Christopher Pocock, John M Goldman, Stephen O'Brien

Blood (2011) 118 (21): 785.

https://doi.org/10.1182/blood.V118.21.785.785

Published: 2011

Journal Articles

Assessment of BCR-ABL1 Transcript Levels At 3 Months Is the Only Requirement for Predicting Outcome for Patients with Chronic Myeloid Leukemia Treated with Imatinib

Dragana Milojkovic, MD, Amr R Ibrahim, Letizia Foroni, MD PhD, Claire Lucas, Gareth Gerrard, PhD, Lihui Wang, Richard M Szydlo, Richard E Clark, Jane F Apperley, MBChB, MD, FRCP, FRCPath, Marco Bua, MD, Jiri Pavlu, Christos Paliompeis, Alistair Reid, PhD, Katy Rezvani, MBBS, PhD, MRCP, FRCPath, John M Goldman, David Marin

Blood (2011) 118 (21): 1680.

https://doi.org/10.1182/blood.V118.21.1680.1680

Published: 2011

NARROW

Cryopreserved Allogeneic Peripheral Blood Stem Cells Result in Outcome Equivalent to Those of Fresh Infusions Enabling Rational Scheduling of Donations,

Chronic Myeloid Leukemia Patients on Tyrosine Kinase Inhibitor Have Normal T Cell Responses to Vaccination but An Impaired IgM Humoral Response Associated with Loss of Discrete Memory B Cell Subsets,

Elevated Preconditioning Serum Levels of C-Reactive Protein Are Associated with Increased Nonrelapse Mortality and Inferior Survival After Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation

Prolonged Survival Following Imatinib Failure for CML Patients in CP May Require Multiple TKI Strategies for Responding Patients,

Thrombopoietic Agonists Show Efficacy in ITP Related to Allogeneic Stem Cell Transplantation,

Initial Findings From the PACE Trial: A Pivotal Phase 2 Study of Ponatinib in Patients with CML and Ph+ ALL Resistant or Intolerant to Dasatinib or Nilotinib, or with the T315I Mutation

Allogeneic Stem Cell Transplantation Induces Long Term Survival in Pateitns with Advanced Chronic Myeloid Leukaemia:A Study of the British Society for Blood and Marrow Transplantation,

The Majority of Patients Receiving Donor Lymphocyte Infusions for Relapsed Chronic Myeloid Leukemia Remain PCR Positive Despite Maintaining Long-Term Remission,

Stem Cell Mobilization in Poor Mobilizers Using Plerixafor and G-CSF with or without Chemotherapy: A European Perspective

The Natural History of RTQ-PCR Levels After the Achievement of Complete Molecular Remission (CMR): Implications for ‘Stopping' Studies

The Predictive Value of Early Molecular Response in Chronic Phase CML Patients Treated with Dasatinib First Line Therapy

Assessment of BCR-ABL1 Transcript Levels At 3 Months Is the Only Requirement for Predicting Outcome for Patients with Chronic Myeloid Leukemia Treated with Imatinib

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only